BIOCRYST PHARMACEUTICALS INC
BCRX
DELAYED 1 MONTH

12 insider filings · Latest: May 29, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 19 8:07 PMAmy E MckeeDirector
Sale
11,180$8.97$100.3K31,252(D)

View →

May 13, 2026May 15 8:08 PMAlane P BarnesChief Legal Officer
Sale
62,500$9.54$596.3K400,703(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 13, 2026May 15 8:08 PMAlane P BarnesChief Legal Officer
Option Exercise
62,500$5.040(D)

View →

Mar 2, 2026Mar 3 9:34 PMJon P StonehouseDirector
Option Exercise
305,995$3.220(D)

View →